Tirzepatide Cost: How Much Does It Cost Per Month?


Published August 20, 20267 min read

Medically reviewed by Dr. Kavya Patel, MD. Pricing is accurate as of August 2026 and subject to change.


Key Takeaways

  • Brand-name Zepbound/Mounjaro pens list at roughly $1,086/month regardless of dose.
  • Compounded tirzepatide at MaxLife starts at $120/month, below the general compounded market range of $250-$500.
  • Eli Lilly's LillyDirect self-pay vials run $299-$449/month depending on dose, if you refill within 45 days.
  • Insurance costs vary widely: as low as $25/month with a savings card, or $100-$300+ on a high-deductible plan.
  • There is no FDA-approved generic tirzepatide, so pricing pressure comes only from the compounded route or savings programs.

Tirzepatide Cost Comparison Table

The table below puts all four routes side by side so you can see exactly where the differences come from.

OptionTypical monthly costInsurance requiredWhat's included
Mounjaro pens (brand-name)~$1,080/moNo (list price)Medication only
Zepbound pens (brand-name)~$1,086/moNo (list price)Medication only
Zepbound self-pay vials (LillyDirect)$299–$449/moNoMedication only
Compounded tirzepatide (general market)$250–$500/moNoVaries by provider
MaxLife compounded tirzepatide$120/moNoMedication, supplies, provider review, shipping

The same active ingredient can cost more than five times as much depending on the route you take. Someone paying brand-name pen list price for Zepbound faces over $13,000 a year. The MaxLife monthly plan comes to $2,340 a year.

What separates these options is not the medication itself but the distribution model, what is bundled into the price, and whether you are carrying a brand-name markup.

How Much Is Tirzepatide Without Insurance?

Without insurance, three realistic paths exist for accessing tirzepatide. The first is paying the full cash price for brand-name pens at a retail pharmacy. The second is using Eli Lilly's own reduced-price self-pay vial program through LillyDirect. The third is compounded tirzepatide through a telehealth provider, which is the lowest-cost legitimate route available today.

All three deliver the same active ingredient, but at significantly different monthly costs and in different formats.

Brand-Name Pen List Prices

Mounjaro lists at approximately $1,080 per 28-day supply of four pens. Zepbound lists at $1,086.37. Both prices hold flat regardless of dose strength, and both represent the wholesale acquisition cost, the price Eli Lilly charges wholesalers, which is what most people without coverage or an active savings program face at a retail pharmacy counter.

For Zepbound pens, dose escalation does not change what you pay. Whether you are on the 2.5 mg starter dose or the maximum 15 mg dose, the monthly pen price is the same. The vial program works differently, which the next section covers.

Eli Lilly publishes both WAC figures on its official pricing pages at pricinginfo.lilly.com.

Self-Pay Vials Through the Manufacturer

Eli Lilly sells Zepbound in single-dose vials at reduced prices through the Self Pay Journey Program on LillyDirect, its direct pharmacy platform. Current 2026 pricing through this program is:

  • 2.5 mg: $299 per month
  • 5 mg: $399 per month
  • 7.5 mg through 15 mg: $449 per month

The key condition: the reduced program rate applies only when you refill within 45 days of your previous delivery. Miss that window and the standard non-program pricing applies, which runs significantly higher for the higher doses.

The format also differs from pens. Vials require you to draw and inject the medication yourself rather than clicking a pre-loaded auto-injector. For people comfortable with self-injection, this is a manageable difference. But it is a practical shift worth knowing about before choosing this route.

Pricing is subject to change and should be confirmed at lilly.com/lillydirect at the time of purchase.

Compounded Tirzepatide Cost

Compounded tirzepatide contains the same active ingredient as Mounjaro and Zepbound, but is prepared by a licensed compounding pharmacy rather than manufactured at scale by Eli Lilly. Because it bypasses the brand-name manufacturing, distribution, and marketing costs built into the pen price, the monthly cost is substantially lower. Typical market pricing runs from about $250 to $500 a month, though the range varies by provider, dose, and what is bundled into the price.

One point to state clearly: compounded medications are not FDA-approved. The FDA does not review them for efficacy, safety, or manufacturing consistency the way it does brand-name drugs. Quality and consistency depend on the pharmacy preparing the medication.

This route only makes sense through a provider working with properly licensed 503A or 503B pharmacies. A 503A pharmacy compounds for individual patients with a prescription. A 503B outsourcing facility operates under stricter FDA oversight and compounds in larger quantities. Either way, the pharmacy should be named and independently verifiable before you commit to any program.

MaxLife has licensed pharmacy partners such as Hallandale Pharmacy, Red Rock Pharmacy, and Strive Pharmacy. This transparency is the signal to look for when comparing compounding providers.

How Much Does Tirzepatide Cost With Insurance?

There is no single answer, because coverage depends on whether tirzepatide is on your plan's formulary, which tier it sits on, what the medication is prescribed for, and whether you have met your deductible.

Coverage for obesity remains far less consistent than coverage for type 2 diabetes. As of 2025, about 36% of employers covered GLP-1 medications for weight loss, while 55% covered them for diabetes only, according to employer benefit surveys. For anyone without a diabetes diagnosis, the odds of having weight-loss coverage are considerably lower, and prior authorization adds another layer of uncertainty even when nominal coverage exists.

What You Might Pay by Plan Type

What you actually pay varies significantly by situation. These ranges are general estimates. Your specific cost depends on your plan's formulary, your current deductible status, and tier placement:

  • Commercial insurance plus a manufacturer savings card: As low as $25 for a one-to-three-month supply if you meet eligibility criteria. Savings cards are not available to Medicare or Medicaid patients.
  • Low-deductible plan with tirzepatide on a preferred tier: Roughly $30 to $75 a month.
  • High-deductible plan before the deductible is met: Roughly $100 to over $300 a month.
  • Medicaid (for diabetes): Often $0 to $10 per month.
  • Medicare Part D (for diabetes): Roughly $40 to $100 a month.

Medicare does not currently cover tirzepatide for weight loss alone. Coverage under Part D applies only when tirzepatide is prescribed for type 2 diabetes. These ranges will also shift as plan years reset and formularies change.

Prior Authorization and Denials

Even when coverage exists on paper, prior authorization is the barrier most people actually hit. Plans typically require documentation of a BMI of 30 or higher, or 27 or higher with at least one weight-related condition such as hypertension, sleep apnea, or type 2 diabetes. Most also require evidence of prior weight-loss attempts, such as participation in a structured program or prior medication use.

If your claim is denied, the steps are:

  1. Request the written denial letter, which must specify the reason for the denial.
  2. Ask your prescriber for a letter of medical necessity that addresses that specific reason.
  3. File an internal appeal with your insurance plan, typically within 60 to 180 days of the denial date.
  4. If the internal appeal is also denied, pursue external review through an independent organization, which is available in most states.

The process is slow. Many people spend weeks navigating it, and a significant share choose to pay out of pocket rather than wait. That is the point at which compounded tirzepatide becomes a practical consideration, even for people who technically have coverage on their plan.

Tirzepatide Cost Per Month at MaxLife

MaxLife offers compounded tirzepatide at $120 a month on the monthly plan. That price includes the medication, supplies, licensed provider review, ongoing support, and free overnight shipping. No insurance is required.

Plans are FSA and HSA eligible, which means you can apply pre-tax funds to offset the monthly cost if you have either account available.

The medication is prepared by named, licensed pharmacy partners: Hallandale Pharmacy, Red Rock Pharmacy, and Strive Pharmacy. Unlike providers who list a pharmacy partner generically, MaxLife names each one, which makes independent verification straightforward.

Compared to the other routes covered earlier in this article, MaxLife's $120 monthly rate sits below the general compounded market range of $250 to $500, well below the $299 to $449 Zepbound vial range, and a fraction of the $1,086 brand-name pen list price.

No long-term contract is required. You can cancel with 30 days' notice before your next billing period begins.

What Makes Tirzepatide So Expensive?

Several factors drive the high cost of tirzepatide, and none of them are likely to shift quickly.

The most significant is the absence of any FDA-approved generic. When brand-name drugs face generic competition, prices typically fall sharply. Tirzepatide's patents remain in effect, which means Mounjaro and Zepbound have no low-cost generic competitors pulling prices down at retail pharmacies.

Pharmacy benefit managers also shape what patients pay. These intermediaries negotiate between manufacturers and health plans, determine which drugs land on which formulary tier, and set the restrictions that govern access. Their decisions affect the out-of-pocket cost for millions of patients.

High and sustained demand is a contributing factor as well. GLP-1 medications have seen rapid uptake, and strong demand without meaningful supply constraints gives manufacturers less incentive to reduce list prices.

Finally, weight-loss coverage is treated as elective by most health plans, pushing more of the cost burden onto patients directly. For Zepbound self-pay vials, dose strength does affect cost, unlike pens, where the list price holds flat across all doses.

Watch Out for Hidden Fees

The advertised monthly price for tirzepatide through a telehealth provider is often not the total you will actually pay. Many platforms add membership fees, consultation charges, lab work, coaching, or shipping costs on top of the medication price. Some quote a low introductory rate that rises significantly at your first refill.

Before signing up with any provider, ask the following questions:

  • Is the medication included in the monthly price, or billed separately?
  • Are supplies such as needles and alcohol wipes included?
  • Is shipping included, or added per shipment?
  • Is there a separate membership or platform fee on top of the medication cost?
  • Does the price change after the first month or the first billing period?
  • Is there a minimum contract period or a cancellation penalty?

At MaxLife, the medication and supplies are included in the monthly plan price. Shipping is free overnight. There is no separate membership fee layered on top, and no long-term contract is required.

The only number worth comparing between providers is the total monthly cost with everything included. A low headline price that excludes shipping and supplies can easily match or exceed a higher stated rate that bundles everything in.

How to Lower Your Tirzepatide Cost

If the standard pricing options are out of reach, these are the most effective legitimate routes to reduce what you pay:

  • Manufacturer savings cards: Both Mounjaro and Zepbound offer savings cards for people with commercial insurance, reducing out-of-pocket costs to as little as $25 a month. These are not available to Medicare or Medicaid patients.
  • Zepbound self-pay vials: Eli Lilly's Self Pay Journey Program starts at $299 a month for the 2.5 mg dose through LillyDirect, available without insurance.
  • Prescription discount cards: Services such as GoodRx can reduce retail pharmacy costs, though savings vary significantly by location and participating pharmacy.
  • Patient assistance programs: The PAN Foundation provides financial assistance to qualifying patients based on income eligibility criteria.
  • Multi-month billing: Choosing a quarterly or multi-month plan over a monthly billing cycle typically lowers the effective monthly rate with telehealth providers.
  • Compounded tirzepatide through a licensed provider: The lowest-cost legitimate route, provided you use a provider working with properly licensed 503A or 503B pharmacies in your state.

One caution applies across all of these: only use telehealth providers with physicians licensed in your state and pharmacy partners that are named and independently verifiable. Unlicensed or unverifiable compounding pharmacies carry real quality and safety risks that offset any savings.

Is Tirzepatide Worth the Cost?

Whether tirzepatide is worth the cost depends significantly on which cost you are comparing and which patient is asking.

A 2025 modeling study published in the journal Obesity estimated a net price of approximately $6,236 per year for tirzepatide and found that a price reduction of roughly 30% would be needed for the treatment to meet standard US cost-effectiveness thresholds. That analysis applied to brand-name pricing, not to the compounded self-pay route, where the math looks different.

Those same models weigh long-term benefits that go beyond the scale, including reductions in cardiovascular risk and improvements in type 2 diabetes outcomes. For patients with those underlying conditions, the cost-effectiveness calculation shifts compared to someone pursuing weight loss alone.

The real-world variable worth factoring in is treatment duration. Patients who stop early or who regain weight after stopping get less value from what they spent. A sustainable monthly cost, one that someone can realistically maintain for a year or more, generally produces better outcomes than the cheapest possible first month followed by a gap in treatment.

How Much Does Semaglutide Cost?

Semaglutide follows the same general pricing structure as tirzepatide. Brand-name pens list at high prices comparable to tirzepatide's range, while the compounded route brings the monthly cost down substantially.

At MaxLife, compounded semaglutide starts at $100 a month on the quarterly plan, which is lower than the tirzepatide starting price and a meaningful consideration for anyone weighing which medication to begin with.

The decision between semaglutide and tirzepatide should be a clinical one, based on your response, tolerance, and medical history rather than price alone. Clinical trial data shows tirzepatide producing greater average weight loss, though individual results vary. Cost is a reasonable secondary factor once the clinical direction is clear.

Conclusion

Tirzepatide cost spans roughly $120 to over $1,086 a month depending on the route you take. Brand-name pens list at approximately $1,086, manufacturer self-pay vials run $299 to $449 through the Self Pay Journey Program, compounded options typically run $250 to $500, and insurance outcomes range from about $25 with a savings card to over $300 on a high-deductible plan. There is no generic, so savings come from the compounded route or from active savings programs.

For a full view of available GLP-1 weight loss programs, MaxLife covers both semaglutide and tirzepatide. Always compare total monthly cost including all fees before committing to any provider or plan.

Tirzepatide Cost FAQs

How much does tirzepatide cost per month without insurance?

Without insurance, tirzepatide cost ranges from $120 a month for compounded tirzepatide through a provider like MaxLife, to $299 to $449 a month for Zepbound self-pay vials through LillyDirect, to approximately $1,086 at brand-name pen list price. The compounded route is the lowest-cost legitimate option for uninsured adults.

Why is compounded tirzepatide cheaper than Zepbound?

Compounded tirzepatide is prepared by a licensed compounding pharmacy rather than manufactured at scale by Eli Lilly. It bypasses the brand-name manufacturing, distribution, and marketing costs built into Zepbound's price. The active ingredient is the same, but compounded medications are not FDA-approved and their quality depends on the specific pharmacy producing them.

Does insurance cover tirzepatide for weight loss?

Coverage for weight loss is far from universal. As of 2025, about 36% of employers covered GLP-1 medications for weight loss. Coverage depends on whether tirzepatide is on your plan's formulary, your diagnosis, and whether prior authorization is approved. Medicare does not currently cover tirzepatide for weight loss alone.

Is there a generic version of tirzepatide?

No. There is no FDA-approved generic version of tirzepatide. Eli Lilly's patents remain in effect, which keeps brand-name list prices high and means no low-cost generic alternative exists at retail pharmacies.

Can I use my HSA or FSA to pay for tirzepatide?

In most cases, yes. HSA and FSA funds can be used for prescription medications, including compounded tirzepatide prescribed for a qualifying medical condition. MaxLife plans are FSA and HSA eligible. Check with your plan administrator if you are uncertain whether your specific account covers compounded medications.

What happens to the price when I move up to a higher dose?

For brand-name pens, the list price stays flat regardless of dose. A 2.5 mg pen and a 15 mg pen list at the same monthly price. For Zepbound self-pay vials, the price increases with dose: $299 for 2.5 mg, $399 for 5 mg, and $449 for higher doses through the Self Pay Journey Program. For compounded tirzepatide through providers like MaxLife, dose changes may affect pricing depending on the specific plan.

Skip the Wait. Check Your Eligibility With MaxLife

Compounded medications are not FDA-approved and are not covered by insurance. Pricing and availability are subject to change.

Check Your Eligibility

This article is for informational purposes only and does not constitute medical advice. Maxlife Technologies Inc.™ is a patient management platform that collaborates with independent physicians and practitioners; it is not a drug manufacturer or compounding pharmacy. Compounded medications are not subject to pre-market review or FDA approval and may differ from commercially available drugs in efficacy, safety, and side-effect profile. Pricing, program details, and third-party costs referenced in this article (Zepbound, Mounjaro, LillyDirect) are subject to change, always confirm current pricing directly with the manufacturer or provider before making a decision.

Sources